MedPath

HYPAQUE-M 76% LIQ

HYPAQUE-M 76% LIQ

Discontinued
DIN Number

02026996

Drug Class

Human

Market Date

Dec 31, 1969

Company
HC

sanofi canada, inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02026996
AIG Number0201807001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AA01 DIATRIZOIC ACID
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous ,  Intra-Arterial
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

DIATRIZOATE MEGLUMINEActive
Strength: 66 %
Monograph: DIATRIZOATE MEGLUMINE
DIATRIZOATE SODIUMActive
Strength: 10 %
Monograph: DIATRIZOATE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.